Skip to main content

Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa.

Publication ,  Journal Article
Kaye, KS; Kanafani, ZA; Dodds, AE; Engemann, JJ; Weber, SG; Carmeli, Y
Published in: Antimicrobial agents and chemotherapy
June 2006

Due to the greater in vitro activity of ciprofloxacin than that of levofloxacin against Pseudomonas aeruginosa, the likelihood of isolating a clinical strain of quinolone-resistant (QR) P. aeruginosa might be greater after exposure to levofloxacin than ciprofloxacin. We examined the risk of isolating QR P. aeruginosa in association with prior levofloxacin or ciprofloxacin exposure. A case-case-control study was conducted. Two groups of cases, one with nosocomial QR P. aeruginosa infections and one with nosocomial quinolone-susceptible (QS) P. aeruginosa infections, were compared to a control group of hospitalized patients without P. aeruginosa infections. Bivariable and multivariable analyses were used to determine risk factors for isolation of QR P. aeruginosa and QS P. aeruginosa. One hundred seventeen QR P. aeruginosa and 255 QS P. aeruginosa cases were identified, and 739 controls were selected. Exposures to ciprofloxacin were similar among all three groups (8% for controls, 9.4% for QR P. aeruginosa cases, and 7.5% for QS P. aeruginosa cases; P >/= 0.6). Levofloxacin use was more frequent in the QR P. aeruginosa cases than in the controls (35.9% and 22.1%, respectively; odds ratio [OR] = 2.0; 95% confidence interval [CI] = 1.3 to 3.0) and less frequent in QS P. aeruginosa cases (14.1% of QS P. aeruginosa cases; OR = 0.6; 95% CI = 0.4 to 0.9). In multivariable analysis, levofloxacin, but not ciprofloxacin, was a significant risk factor for isolation of QR P. aeruginosa (OR for levofloxacin = 1.7 [95% CI = 1.0 to 2.9]; OR for ciprofloxacin = 1.2 [95% CI = 0.6 to 2.5]). Levofloxacin was associated with a reduced risk of isolation of QS P. aeruginosa (OR = 0.6; 95% CI = 0.4 to 0.9), whereas ciprofloxacin had no significant effect (OR = 1.0; 95% CI = 0.6 to 1.8). In conclusion, the use of levofloxacin, but not ciprofloxacin, was associated with isolation of QR P. aeruginosa.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Antimicrobial agents and chemotherapy

DOI

EISSN

1098-6596

ISSN

0066-4804

Publication Date

June 2006

Volume

50

Issue

6

Start / End Page

2192 / 2196

Related Subject Headings

  • Risk Factors
  • Retrospective Studies
  • Regression Analysis
  • Quinolones
  • Pseudomonas Infections
  • Ofloxacin
  • Middle Aged
  • Microbiology
  • Male
  • Levofloxacin
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kaye, K. S., Kanafani, Z. A., Dodds, A. E., Engemann, J. J., Weber, S. G., & Carmeli, Y. (2006). Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 50(6), 2192–2196. https://doi.org/10.1128/aac.00060-06
Kaye, Keith S., Zeina A. Kanafani, Ashley E. Dodds, John J. Engemann, Stephen G. Weber, and Yehuda Carmeli. “Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa.Antimicrobial Agents and Chemotherapy 50, no. 6 (June 2006): 2192–96. https://doi.org/10.1128/aac.00060-06.
Kaye KS, Kanafani ZA, Dodds AE, Engemann JJ, Weber SG, Carmeli Y. Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy. 2006 Jun;50(6):2192–6.
Kaye, Keith S., et al. “Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa.Antimicrobial Agents and Chemotherapy, vol. 50, no. 6, June 2006, pp. 2192–96. Epmc, doi:10.1128/aac.00060-06.
Kaye KS, Kanafani ZA, Dodds AE, Engemann JJ, Weber SG, Carmeli Y. Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy. 2006 Jun;50(6):2192–2196.

Published In

Antimicrobial agents and chemotherapy

DOI

EISSN

1098-6596

ISSN

0066-4804

Publication Date

June 2006

Volume

50

Issue

6

Start / End Page

2192 / 2196

Related Subject Headings

  • Risk Factors
  • Retrospective Studies
  • Regression Analysis
  • Quinolones
  • Pseudomonas Infections
  • Ofloxacin
  • Middle Aged
  • Microbiology
  • Male
  • Levofloxacin